Indications And Dose
Primary immunisation against measles, mumps, and rubella (first dose) ▶BY INTRAMUSCULAR INJECTION, OR BY DEEP SUBCUTANEOUS INJECTION ▶Child 12–13 months: 0.5 mL for 1 dose Primary immunisation against measles, mumps, and rubella (second dose) ▶BY INTRAMUSCULAR INJECTION, OR BY DEEP SUBCUTANEOUS INJECTION ▶Child 40 months–5 years: 0.5 mL for 1 dose Rubella immunisation (in seronegative women, susceptible to rubella and in unimmunised, seronegative women, post-partum) ▶BY INTRAMUSCULAR INJECTION, OR BY DEEP SUBCUTANEOUS INJECTION ▶Females of childbearing potential: (consult product continued → literature or local protocols) Children presenting for pre-school booster, who have not received the primary immunisation (first dose) | Immunisation for patients at school-leaving age or at entry into further education, who have not completed the primary immunisation course | Control of measles outbreak | Immunisation for patients travelling to areas where measles is endemic or epidemic, who have not completed the primary immunisation ▶BY INTRAMUSCULAR INJECTION, OR BY DEEP SUBCUTANEOUS INJECTION ▶Child 6 months–17 years: (consult product literature or local protocols) ▶Adult: (consult product literature or local protocols) l UNLICENSED USE ▶In children Not licensed for use in children under 9 months.
PDF pages 1415, 1416